Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bioaffinity Technologies WT (BIAFW)

Bioaffinity Technologies WT (BIAFW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 9,360 K
  • Annual Income, $ -9,040 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/13/25
  • Annual Dividend & Yield 0.00 (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2201 unch
on 12/04/25
0.4145 -46.90%
on 11/07/25
-0.1299 (-37.11%)
since 11/04/25
3-Month
0.0601 +266.22%
on 09/19/25
0.8121 -72.90%
on 10/10/25
+0.1501 (+214.43%)
since 08/22/25
52-Week
0.0525 +319.24%
on 08/21/25
0.8121 -72.90%
on 10/10/25
-0.5099 (-69.85%)
since 12/02/24

Most Recent Stories

More News
bioAffinity Technologies’ Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society National Lung Cancer Roundtable

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW) , a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today announced...

BIAF : 1.7200 (+9.55%)
BIAFW : 0.2201 (-26.63%)
bioAffinity Technologies Reports Third Quarter 2025 Financial Results

Company achieves 86% increase in CyPath® Lung testing revenue, strengthens balance sheet

BIAF : 1.7200 (+9.55%)
BIAFW : 0.2201 (-26.63%)
bioAffinity Technologies Announces Acceptance of Australian Patent Application for Platform to Detect and Characterize Multiple Lung Diseases

Australian patent strengthens global patent portfolio

BIAF : 1.7200 (+9.55%)
BIAFW : 0.2201 (-26.63%)
bioAffinity Technologies Presents Research Supporting CyPath® Lung Processing Methods at CHEST 2025

Visit the CyPath® Lung team at Booth #2242 October 19-22

BIAF : 1.7200 (+9.55%)
BIAFW : 0.2201 (-26.63%)
bioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer

U.S. award protects AI-built platform and adds to growing international patent portfolio

BIAF : 1.7200 (+9.55%)
BIAFW : 0.2201 (-26.63%)
bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing early-stage cancer diagnostics including CyPath® Lung , the Company’s...

BIAF : 1.7200 (+9.55%)
BIAFW : 0.2201 (-26.63%)
WallachBeth Capital Announces The Closing of bioAffinity Technologies $1.8M Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

JERSEY CITY, N.J. , Oct. 9, 2025 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that bioAffinity Technologies,...

BIAF : 1.7200 (+9.55%)
BIAFW : 0.2201 (-26.63%)
bioAffinity Technologies, Inc. Announces Closing of $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

bioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW) a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today announced...

BIAF : 1.7200 (+9.55%)
BIAFW : 0.2201 (-26.63%)
WallachBeth Capital Announces bioAffinity Technologies Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

JERSEY CITY, N.J. , Oct. 8, 2025 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that bioAffinity Technologies,...

BIAF : 1.7200 (+9.55%)
BIAFW : 0.2201 (-26.63%)
bioAffinity Technologies, Inc. Announces Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

bioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW) , a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today announced...

BIAF : 1.7200 (+9.55%)
BIAFW : 0.2201 (-26.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar